Riskpilot← Back to searchSign inGet full accessCurevac Aktiebolag
ABActiveOrg 5561728394Föreningsgatan 4 AWholesale of other intermediate products · NACE 4686Est. 19721 employees
Revenue 2024
SEK 10,6M
-1% vs 2023
EBITDA margin
3.2%
+1790% vs 2023
Equity ratio
54.3%
Financial strength
Net profit 2024
SEK 335K
+196% vs 2023
| Revenue | SEK 10,6M | -1% |
| EBITDA | SEK 338K | +1790% |
| Net profit | SEK 335K | +196% |
| Total assets | SEK 5,8M | +5% |
| Equity | SEK 3,1M | +12% |
| Employees | 1 | — |
Legal name
Curevac Aktiebolag
Org number
5561728394
Legal form
Aktiebolag
NACE code
4686 · Wholesale of other intermediate products
Founded
30 november 1972
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall driva handel med emballagematerial, bedriva handel med värdepapper samt att idka därmed förenlig verksamhet.
Address
Föreningsgatan 4 A
Phone
+4631133203
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 529 | 10 026 | 12 036 | 10 729 | 10 641 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 412 | 777 | 768 | −20 | 338 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 412 | 777 | 768 | −20 | 338 |
| Net financials | 2 | 3 | 22 | 21 | 32 |
| Profit before tax | 564 | 675 | 741 | 161 | 445 |
| Tax | −132 | −149 | −168 | −48 | −110 |
| Net profit | 432 | 526 | 573 | 113 | 335 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 434 | 7 056 | 6 559 | 5 481 | 5 771 |
| Equity | 2 590 | 3 116 | 3 688 | 2 801 | 3 136 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 554 | 2 545 | 1 425 | 1 395 | 1 425 |
| Total debt | 2 554 | 2 545 | 1 425 | 1 395 | 1 425 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20202024
Equity ratio
54.3%
This company
38.2%
Market median
+42% vs market
20202024
Return on equity
10.7%
This company
18.4%
Market median
+42% vs market
20202024
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20202024
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
20202024
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EC | Audit | 2024 |
JB Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
KG Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Curevac International Aktiebolag
Curevac Aktiebolag Board members of Curevac Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Chris Nettervik Carlsson | Audit | 0 companies |
| Kjell Göran Carlsson | Audit | 0 companies |
| John Bendis Ekedahl | Chief Executive Officer | 0 companies |
| Carsten Nils Erik Browall | Deputy Board Member | 0 companies |